Skip to main content

Table 2 Summary of Adverse Events

From: Efficacy of fixed-dose amlodipine and losartan combination compared with amlodipine monotherapy in stage 2 hypertension: a randomized, double blind, multicenter study

Adverse Events Amlodipine/Losartan
(N = 73)
Amlodipine
(N = 75)
p-value
  n (%) [number of reported AEs] n (%) [number of reported AEs]  
Treatment-Emergent Adverse Events 23 (31.5) [44] 24 (32.0) [42] 0.9486(a)
  Mild 20 (27.4) [41] 21 (28.0) [39] 1.0000(b)
Severity Moderate 3 (4.1) [3] 2 (2.7) [2] ns
  Severe 0 [0] 1 (1.3) [1]  
Drug-related AE 8 (11.0) [14] 13 (17.3) [20] 0.2665(a)
Serious AE 2 (2.7) [2] 1 (1.3) [1] 0.6173(b)
AE which causes rule-out 2 (2.7) [2] 0 [0] 0.2416(b)
Death 0 [0] 0 [0]  
  1. (a) Pearson's chi-square test
  2. (b) Fisher's exact test